Triciribine is a nucleoside analog and an inhibitor of the Akt signaling pathway, primarily investigated in clinical research for its potential as an antineoplastic agent in the treatment of various malignancies,… Read more
Triciribine is a nucleoside analog and an inhibitor of the Akt signaling pathway, primarily investigated in clinical research for its potential as an antineoplastic agent in the treatment of various malignancies, including leukemia, ovarian cancer, and advanced breast cancer. Laboratories utilize this category of compounds, which includes Triciribine API, its phosphate salt, and stable isotope-labelled analogs, as essential reference standards for critical analytical applications. These high-quality materials are vital for method validation, impurity profiling, and the accurate quantification of drug levels during pharmacokinetic studies. By employing these precise reference materials, researchers ensure rigorous quality control and reliable data interpretation throughout the development and evaluation of this investigational therapeutic. The availability of stable isotope-labelled versions is particularly valuable in liquid chromatography-mass spectrometry (LC-MS) assays, where they serve as internal standards to correct for matrix effects and variations in experimental conditions.